PME Investimentos
VC Fund
Porto, Portugal
PME Investimentos is a state owned investment company who supports entrepreneurship, innovation, competitiveness and the internationalization of the Portuguese economy. Subject to the supervision of the Portuguese Central Bank, PME Investimentos has been supporting Portuguese companies for the last 30 years through special investment vehicles andfunds, investing trough equity instruments and managing debt instruments, in partnership with Banks and the Mutual Guarantee System.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 23%
Last updated:
For AI agents: llms.txt
Industries PME Investimentos invests in
Stages PME Investimentos invests in
Countries PME Investimentos invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Joana Costa
|
|||
|
Joao Sardinha
|
|||
Marco Fernandes
|
|||
|
Paula Ferreira
|
|||
|
Rodrigo Paulino
|
|||
| See all 9 contacts → | |||
Investment Focus
Industry
- Health Care 4 (31%)
- Made to Order 3 (23%)
- Medical Device 3 (23%)
- B2B 2 (15%)
- Medical 2 (15%)
Stage
- Seed 6 (46%)
- Series A 3 (23%)
- Series B 2 (15%)
- Funding Round 2 (15%)
Country
- Portugal 10 (77%)
- France 1 (8%)
- United Kingdom 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Joana Costa
Funds Controller
|
Funds Controller | Total investments: 0 | Find email | |
|
Joao Sardinha
Funds Manager
|
Funds Manager | Total investments: 0 | Find email | |
|
Marco Fernandes
CEO
|
CEO | Total investments: 3 | Find email | |
|
Paula Ferreira
Head of Funds Department
|
Head of Funds Department | Total investments: 0 | Find email | |
|
Rodrigo Paulino
Funds Manager
|
Funds Manager | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Knokcare
|
Knok is an app-based healthcare platform offering patients a holistic solution for their health through a combination of AI chatbots, video calls, face to face appointments at home, and integration with hospitals in one single application. This solution is convenient for the patient and efficient for the health system: the AI chatbot helps patientsself-assess their condition and directs the patient within the app to a video appointment or a face to face appointment. If the issue is serious enough, knock will direct the patient to the hospital. | $1.8M / Seed / Nov 02, 2020 | |
Aptoide
|
Aptoide is a Marketplace in the Android Platform with over 1.5 Million daily active users. It allows Developers, OEM, Telcos and Integrators to create and manage their own Android store.Our partners can also upload and distribute their Android Apps through their own stores. We have an open-source version of the client, although Aptoidealso provides customization, branding and services to our partners, adding value over the open-source version.Aptoide is a very fast growing incorporated company with solid grounds. | $1.4M / Oct 30, 2020 | |
Nutrium
|
With the Nutrium platform, millions of patients will experience the most integrated and effective nutrition counselling service which will combine professional advice, continuous monitoring and seamless access to commercial products. | $4.7M / Seed / Oct 13, 2020 | |
Didimo
|
Didimo is the world’s leading provider of fast, automated solutions for the generation of high-quality real-time humans. Our high-fidelity 3D didimo human avatars are created in around 90 seconds, from inputs as simple as a 2D photo.Our PaaS allows content creators, software developers, collaboration platforms, and app builders to integrate afast, robust, and reliable solution for generating user-generated avatars in their own software solutions. Our patented and flexible pipeline can translate various image-based inputs of a user’s face, and using automated machine vision, topology generation, texturing, and rigging components, to output a real-time ready high fidelity avatar. These are designed to be perfectly suited for real-time engines - and include a full facial animation system and text-to-speech animation capability. | $1.1M / Sep 22, 2020 | |
|
Didimo
|
Didimo is the world’s leading provider of fast, automated solutions for the generation of high-quality real-time humans. Our high-fidelity 3D didimo human avatars are created in around 90 seconds, from inputs as simple as a 2D photo.Our PaaS allows content creators, software developers, collaboration platforms, and app builders to integrate afast, robust, and reliable solution for generating user-generated avatars in their own software solutions. Our patented and flexible pipeline can translate various image-based inputs of a user’s face, and using automated machine vision, topology generation, texturing, and rigging components, to output a real-time ready high fidelity avatar. These are designed to be perfectly suited for real-time engines - and include a full facial animation system and text-to-speech animation capability. | $1.1M / Seed / Sep 22, 2020 | |
PICadvanced
|
PICadvanced is specialized in solving complex problems through optics, namely through optical chip design, development and packaging. | $4.4M / Series A / Aug 05, 2020 | |
EatTasty
|
EatTasty produces every-day tasty food through a decentralized model, aiming to deliver the best food through the biggest community of producers. | $705K / Seed / Dec 02, 2019 | |
Barkyn
|
Delivering health and happiness to pet families, reshaping the future of e-commerce. | $1.2M / Seed / Oct 07, 2019 | |
PlatformE
|
The new standard for made-to-order production (MTO). Platforme is powering at scale customization, personalization and digital collections across industries. We are enabling the world’s transition to waste-free and sustainability, revolutionizing the way brands capitalize on inventory. No more dead stock. | $4.6M / Series A / Sep 03, 2019 | |
LiMM Therapeutics
|
LiMM Therapeutics operates as a biopharmaceutical company that harnesses the molecular cross-talk between neuronal and innate lymphoid cells. It develops products designed to preserve health and treat inflammatory, infectious, and metabolic diseases. The company is dedicated to bridging neural sensing and immunology discoveries to unlocktherapeutic solutions for the benefit of patients. | $2.2M / Seed / Apr 12, 2019 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does PME Investimentos invest in?
PME Investimentos invests primarily in Health Care, Made to Order and Medical Device startups, most often at Seed and Series A stage. Most of the 13 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact PME Investimentos?
Public channels for PME Investimentos include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at PME Investimentos?
The team at PME Investimentos includes Joana Costa (Funds Controller), Joao Sardinha (Funds Manager) and Marco Fernandes (CEO), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
